E-DRUG: Webinar: Implementing Risk-Based Approach to Medicines Quality Surveillance
--------------------------------------------------------------------------------------------
Thursday, February 28 from 10:00 am to 11:00 am (EST) via Webex
How to participate:
1. Ctrl + click here<https://www.usp-pqm.org/resources/knowledge-sharing-videos> to watch the video, Protecting Patients from Bad Drugs: A Risk-Based Approach to Medicines Quality Surveillance (2 parts, approx. 50 minutes), any time before the live Q&A.
2. Use the 'Comment on this Vide' option on the video page to send in your questions ahead of time or keep them ready to ask during the live Q&A.
3. Ctrl + click here<https://uspevents.webex.com/webappng/sites/uspevents/meeting/info/120373292220579137?MTID=m27b4a2a26fa649c3666a3f71ebefd018>
to join the live Q&A on Thursday, February 28 from 10:00am to 11:00am (EST).
Although quality-assured medicines are fundamental to reaching global health goals, many low- and middle-income countries lack robust regulatory systems and programs to monitor the quality of medicines due to limited local resources and capacity, and competing priorities. Poor-quality medicines can cause treatment failure and adverse reactions, increase morbidity and mortality, and contribute to the development of drug resistance. They also waste resources that could otherwise be used to benefit public health.
Designing and implementing programs that monitor medicines quality, also known as post-marketing surveillance, through a risk-based approach allows countries to tailor activities according to local needs, optimize limited resources, and focus efforts on areas that present the greatest risks to public health.
After extensive consultation with international experts, the USAID-funded and USP-implemented Promoting the Quality of Medicines (PQM) program recently published Guidance for Implementing Risk-Based Post-Marketing Quality Surveillance in Low- and Middle-Income Countries
This resource includes a practical tool to help country managers formulate sampling and testing strategies based on risk factors associated with a product, and the epidemiological and country context in which it's used.
To learn more, you are invited to watch a video introduction
<https://www.usp-pqm.org/resources/knowledge-sharing-videos>
on the PQM Website and participate in a live Q&A session
with PQM Principal Program Manager, Timothy Nwogu, on February 28 at 10:00am (EST).
Paul Crystal
USP
Paul.crystal@usp.org